Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening.

• Váldodahkkit: María Pilar Arenaz-Callao (Dahkki), Rubén González Del Río (Dahkki), Ainhoa Lucía Quintana (Dahkki), Charles J Thompson (Dahkki), Alfonso Mendoza-Losana (Dahkki), Santiago Ramón-García (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Public Library of Science (PLoS), 2019-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

The potential use of clinically approved beta-lactams for Buruli ulcer (BU) treatment was investigated with representative classes analyzed in vitro for activity against Mycobacterium ulcerans. Beta-lactams tested were effective alone and displayed a strong synergistic profile in combination with an...